Pfizer prevails over rival Novo Nordisk after an unusual bidding war for the weight-loss startup.
Source link
About The Author
Pfizer has agreed to buy weight-loss drug startup Metsera in a deal that could be worth more than $10 billion, besting rival Novo Nordisk following a heated bidding war